Source: Morning Star

ConvaTec: Convatec Surges 20%, Shares Still Undervalued

Medical company surpasses sales growth expectations, but shares remain undervalued, according to Morningstar's analyst

Read full article »
Annual Revenue
$1.0-5.0B
Employees
10-50K
Karim Bitar's photo - CEO of ConvaTec

CEO

Karim Bitar

CEO Approval Rating

64/100

Read more